DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ASTELIN

« Back to Dashboard

Clinical Trials for Astelin

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00660517	A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies	Completed	Meda Pharmaceuticals	Phase 3	2007-12-01	The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone)
NCT00783432	Study to Evaluate the Safety and Tolerability of a Nasal Spray in Patients With Chronic Allergic or Nonallergic Rhinitis	Completed	Meda Pharmaceuticals	Phase 3	2006-07-01	The purpose of this study is to determine if Astepro Nasal Spray (0.1% azelastine hydrochloride) is as safe as Astelin Nasal Spray (0.1% azelastine hydrochloride)
NCT00883168	A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies	Completed	Meda Pharmaceuticals	Phase 3	2009-04-01	The purpose of this study is to determine if the combination of two allergy medications (formulated azelastine/fluticasone product)is more effective than placebo or either component medication alone (azelastine or fluticasone).
NCT00940953	Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic Rhinitis	Completed	Ligand Pharmaceuticals	Phase 2	2008-02-01	The primary objective of this study was to compare Placebo to Captisol-Enabled Budesonide + Azelastine in a single spray and two separate sprays (Budesonide + Azelastine) in patients with Seasonal Allergic Rhinitis exposed to controlled ragweed pollen.
NCT00979615	Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis	Completed	Alcon Research	Phase 4	2009-09-01	The purpose of this study is to examine safety and efficacy of Patanase and Astelin in treating the symptoms of non-allergic vasomotor rhinitis (VMR).

Clinical Trial Conditions for Astelin

Condition Name

Condition Name for Astelin
Intervention	Trials
Seasonal Allergic Rhinitis	3
Nonallergic Rhinitis	1
Chronic Allergic Rhinitis	1
Allergic Rhinitis	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Astelin
Intervention	Trials
Rhinitis	6
Rhinitis, Allergic	5
Rhinitis, Allergic, Seasonal	3
Rhinitis, Vasomotor	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Astelin

Trials by Country

Trials by Country for Astelin
Location	Trials
United States	25
Germany	1
Canada	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Astelin
Location	Trials
Texas	3
New Jersey	2
California	1
Colorado	1
Georgia	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Astelin

Clinical Trial Phase

Clinical Trial Phase for Astelin
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	3
Phase 2	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Astelin
Clinical Trial Phase	Trials
Completed	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Astelin

Sponsor Name

Sponsor Name for Astelin
Sponsor	Trials
Meda Pharmaceuticals	3
Prolytic GmbH	1
ClinResearch, GmbH	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Astelin
Sponsor	Trials
Industry	7
Other	1

Export unavailable in trial.
Subscribe for complete access.